Targeted Therapy in Salivary Gland Cancer: Prevalence of a Selected Panel of Actionable Molecular Alterations in a German Tertiary Referral Center Patient Cohort

Linxweiler, Maximilian
DOI: https://doi.org/10.1007/s40291-024-00750-w
2024-11-02
Molecular Diagnosis & Therapy
Abstract:Salivary gland carcinomas (SGC) are a heterogeneous group of malignancies, with 24 subtypes defined by the World Health Organization (WHO). The standard of therapy is surgical resection, with adjuvant radiotherapy in most cases. However, disease recurrence (R) or metastasis (M) is common and no active systemic therapies are currently available for RM-SGC resulting in a 5-year survival rate of only 20%.
pharmacology & pharmacy,genetics & heredity
What problem does this paper attempt to address?